Colin Byrd, DO
Otolaryngology · Las Cruces, NMNPI 1063951689
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.9% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Stryker at 26.3% of the total. Reporting peaked in 2021 at $371 and has fallen 81.4% since, to $69 in 2025.
Across 14 payments — averaging $76.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$280
- Cochlear Americas$217
- Aerin Medical Inc.$201
- Intersect ENT, Inc.$145
- Medtronic$114
- GSK$65
- plus $44 from 2 others
What the payments were for
- Food & beverage$1,00194%
- Education$656%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 2 | $280 |
| Cochlear Americas | 3 | $217 |
| Aerin Medical Inc. | 4 | $201 |
| Intersect ENT, Inc. | 1 | $145 |
| Medtronic | 1 | $114 |
| GSK | 1 | $65 |
| Acclarent, Inc | 1 | $27 |
| Smith+Nephew | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XPRESS LOPROFILE$168
- SINUVA$145
- Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$130
- Baha$130
- OSIA OSI300 IMPLANT$130
- PTeye$114
- NA$113
- COLORADO$113
- Vivaer RF Stylus$105
How this compares
$1,065 in reported general payments places this provider in the 70th percentile of 39 otolaryngology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 132 | $2,737 |
| Azelastine Hcl | 56 | $1,566 |
| Ofloxacin | 78 | $1,232 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 11 | $983 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 46 | $718 |
| Ipratropium Bromide | 29 | $553 |
| Mupirocin | 57 | $425 |
| Doxycycline Hyclate | 31 | $336 |
| Amitriptyline Hcl | 24 | $315 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 44 | $305 |
| Levocetirizine Dihydrochloride | 25 | $269 |
| Ciprofloxacin Hcl | 14 | $266 |
| Omeprazole | 15 | $179 |
| Famotidine | 12 | $125 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Las Cruces
- Vittal PaiLas Cruces$121
- Terry McMillanLas Cruces$59
- Jason MuddAlbuquerque$9K
- Ryan OroscoAlbuquerque$8K
- Nizhoni DenipahSanta Fe$8K
- Shervin AminpourAlbuquerque$5K
- Lily LoveAlbuquerque$3K
- Thomas ReichCarlsbad$2K
- Brian HusenRio Rancho$2K
- Noah SymeAlbuquerque$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.